No direct molecular drug-like target

The term "No direct molecular drug-like target" is a classification used in pharmacology to describe therapeutic agents that do not exert their effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or ion channel. Instead, these agents typically function through non-specific physical, chemical, or osmotic mechanisms. Common examples include osmotic diuretics like mannitol, which alter fluid balance, and antacids like magnesium hydroxide, which neutralize gastric acid through direct chemical reaction (DrugBank Online, 2024). This designation is frequently used in pharmacological databases like ChEMBL to categorize drugs where the mechanism of action is well-understood but does not involve a traditional drug-target binding event (ChEMBL Database, 2024). Because these agents lack a specific molecular target, they are generally not evaluated using standard affinity-based assays or high-throughput screening. Understanding this classification is crucial for biotech analysts to distinguish between targeted therapies and those that rely on bulk physiological or chemical changes. These agents often have broad physiological effects and are not subject to typical target-based drug discovery strategies (Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Ed).

Other names

Non-molecular targetNon-specific mechanism of actionUnknown molecular targetPhysicochemical mechanismUnassigned target

Therapeutic effect is achieved through physical, chemical, or osmotic processes rather than binding to a specific biological macromolecule (DrugBank Online, 2024).